Pulmatrix, Inc. 8-K

What Happened

• Pulmatrix, Inc. (PULM) filed a Form 8-K on February 26, 2026 under Item 2.02 to announce its financial results for the fourth fiscal quarter and the twelve months ended December 31, 2025.
• The company furnished a press release reporting those results as Exhibit 99.1 to the filing; readers should consult that press release for the specific reported figures and management commentary.

Key Details

• Filing date: February 26, 2026 (Form 8-K, Item 2.02).
• Reporting periods: Fourth quarter and full year ended December 31, 2025.
• Press release announcing results is furnished as Exhibit 99.1 to the Form 8-K.
• The filing includes interactive data (Inline XBRL) as required for public financial disclosures.

Why It Matters

• Quarterly and full-year results provide the latest confirmed data on Pulmatrix’s earnings, revenue, expenses and cash position for 2025—information that can affect valuation and near-term investor decisions.
• Retail investors should read the furnished press release for the exact revenue, net income/loss, cash runway and any management comments or guidance, since the Form 8-K itself references that exhibit rather than embedding the detailed figures.
• Watch for changes in operating results or liquidity that could influence financing needs, clinical or development plans, and the stock’s short-term performance.